These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8773292)

  • 21. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluating quality of life of depressed patients in ambulatory care treatment].
    Dazord A; Noël F
    Encephale; 1996; 22(4):247-54. PubMed ID: 8940631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients.
    Rahman MK; Akhtar MJ; Savla NC; Sharma RR; Kellett JM; Ashford JJ
    Br J Clin Pract; 1991; 45(4):255-8. PubMed ID: 1810358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa.
    Fichter MM; Leibl C; Krüger R; Rief W
    Pharmacopsychiatry; 1997 May; 30(3):85-92. PubMed ID: 9211569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
    Leonard HL; Meyer MC; Swedo SE; Richter D; Hamburger SD; Allen AJ; Rapoport JL; Tucker E
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1460-8. PubMed ID: 8543513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suitable dose and duration of fluvoxamine administration to treat depression.
    Morishita S; Arita S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):177-81. PubMed ID: 12667164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial.
    Härtter S; Wetzel H; Hammes E; Torkzadeh M; Hiemke C
    Pharmacopsychiatry; 1998 Sep; 31(5):199-200. PubMed ID: 9832352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study.
    Fukuchi T; Kanemoto K
    Int Clin Psychopharmacol; 2002 Mar; 17(2):53-8. PubMed ID: 11890186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression.
    Suzuki Y; Tsuneyama N; Fukui N; Sugai T; Watanabe J; Ono S; Someya T
    Hum Psychopharmacol; 2010 Nov; 25(7-8):525-9. PubMed ID: 20860067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.
    Paulzen M; Finkelmeyer A; Grözinger M
    Pharmacopsychiatry; 2011 Nov; 44(7):317-23. PubMed ID: 21979923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.
    Hollander E; DeCaria CM; Finkell JN; Begaz T; Wong CM; Cartwright C
    Biol Psychiatry; 2000 May; 47(9):813-7. PubMed ID: 10812040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.
    Miyaoka T; Yasukawa R; Mihara T; Shimizu Y; Tsubouchi K; Maeda T; Mizuno S; Uegaki J; Inagaki T; Horiguchi J; Tachibana H
    J ECT; 2003 Sep; 19(3):170-2. PubMed ID: 12972988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluvoxamine (fevarin) in the treatment of depression].
    Sheĭfer MS; Tsybina MI; Davydenko MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):64-7. PubMed ID: 11195542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvoxamine and lithium in long-term treatment of unipolar subjects with high recurrence rate.
    Franchini L; Zanardi R; Gasperini M; Perez J; Smeraldi E
    J Affect Disord; 1996 Apr; 38(1):67-9. PubMed ID: 8735160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients.
    Ikeda M; Shigenobu K; Fukuhara R; Hokoishi K; Maki N; Nebu A; Komori K; Tanabe H
    Dement Geriatr Cogn Disord; 2004; 17(3):117-21. PubMed ID: 14739531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant response and fluvoxamine plasma concentrations: a pilot study.
    Schwarzenbach F; Netillard C; Demoly P; Bisschop D; Limat S; Bouquet S; Vandel S; Bel AM; Woronoff-Lemsi MC
    Pharm World Sci; 2003 Feb; 25(1):27-9. PubMed ID: 12661474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic dose-dependent changes in prophylactic doses of dosulepine, lithium and citalopram.
    Paclt I; Slavícek J; Dohnalová A; Kitzlerová E; Pisvejcová K
    Physiol Res; 2003; 52(3):311-7. PubMed ID: 12790762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Fux M; Taub M; Zohar J
    Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
    Omori IM; Watanabe N; Nakagawa A; Akechi T; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    J Psychopharmacol; 2009 Jul; 23(5):539-50. PubMed ID: 18562407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.